Immunization ScheduleAdvisory CommitteesVaccinationInfluenza VaccinesCommittee MembershipLicensureDiphtheria-Tetanus-acellular Pertussis VaccinesDrug StorageImmunization ProgramsVaccines, CombinedRimantadineVaccinesUnited StatesChickenpox VaccineHepatitis A VaccinesMeasles-Mumps-Rubella VaccineMeningococcal VaccinesMumps VaccineInfluenza, HumanCenters for Disease Control and Prevention (U.S.)Vaccines, InactivatedInfluenza B virusPoliovirus Vaccine, InactivatedPost-Exposure ProphylaxisVaccines, ConjugateDiphtheria-Tetanus-Pertussis VaccineImmunization, SecondaryThimerosalChickenpoxTetanusImmunizationPneumococcal VaccinesHepatitis AMeningococcal InfectionsAmantadineHerpes Zoster VaccineWhooping CoughPreservatives, PharmaceuticalMumpsDiphtheriaProduct Surveillance, PostmarketingDiphtheria ToxoidHepatitis A Virus, HumanVaccines, AttenuatedJapanese Encephalitis VaccinesHepatitis B VaccinesRubella VaccineMass VaccinationImmunocompromised HostSeasonsRotavirus VaccinesMeasles VaccineInfluenza A Virus, H3N2 SubtypeSmallpox VaccineAdoptionTetanus ToxoidHealth PersonnelHaemophilus VaccinesInfluenza A Virus, H1N1 SubtypeSeizures, FebrileTravelUnited States Food and Drug AdministrationImmunocompetenceViral Hepatitis VaccinesPractice Guidelines as TopicPregnancyBioterrorismHerpes ZosterCost-Benefit AnalysisPapillomavirus VaccinesRubellaAntiviral AgentsBacterial VaccinesHealth Planning GuidelinesImmunoglobulins, IntravenousDisease OutbreaksMeaslesInfection ControlCost of IllnessPneumococcal InfectionsNeisseria meningitidisPopulation SurveillanceInfant, NewbornInfluenza A virusRiskRabies VaccinesRabiesRisk FactorsGuideline AdherencePertussis VaccineAge FactorsEthics CommitteesFamily PracticeMedical Laboratory PersonnelExsanguinationProfessional Staff CommitteesDiphtheria-Tetanus VaccineCanadaRisk AssessmentHealth Policy